207 related articles for article (PubMed ID: 3075997)
1. Principles of tumor immunology.
Den Otter W
Postepy Hig Med Dosw; 1988; 42(2):117-24. PubMed ID: 3075997
[No Abstract] [Full Text] [Related]
2. An introduction to tumour immunology.
Keith J
Mater Med Pol; 1984; 16(1):54-64. PubMed ID: 6394909
[No Abstract] [Full Text] [Related]
3. Effector immune mechanisms in cancer.
Lotzová E
Nat Immun Cell Growth Regul; 1985; 4(6):293-304. PubMed ID: 3911064
[No Abstract] [Full Text] [Related]
4. Multiple functions of natural killer cells, including immunoregulation as well as resistance to tumor growth.
Herberman RB
Concepts Immunopathol; 1985; 1():96-132. PubMed ID: 3916408
[No Abstract] [Full Text] [Related]
5. NK cell activating ligands on human malignant cells: molecular and functional defects and potential clinical relevance.
Chang CC; Ferrone S
Semin Cancer Biol; 2006 Oct; 16(5):383-92. PubMed ID: 16931041
[TBL] [Abstract][Full Text] [Related]
6. NK cells and tumor immunity: 1984.
Herberman RB
Year Immunol; 1985; ():93-9. PubMed ID: 3843296
[No Abstract] [Full Text] [Related]
7. Exploiting dendritic cells and natural killer T cells in immunotherapy against malignancies.
Fujii S
Trends Immunol; 2008 May; 29(5):242-9. PubMed ID: 18372215
[TBL] [Abstract][Full Text] [Related]
8. Tumor immunology.
Stevenson HC; Tsang KY
Immunol Ser; 1990; 50():513-33. PubMed ID: 2091767
[No Abstract] [Full Text] [Related]
9. The natural killer cell.
Floyd RA; Fernandes G; Good RA
Clin Bull; 1979; 9(4):146-56. PubMed ID: 232015
[No Abstract] [Full Text] [Related]
10. [Natural killer cells in the interferon therapy of cancer patients].
Shparyk IaV; Bilynskiĭ BT; Shloma DV
Vopr Onkol; 1991; 37(2):136-43. PubMed ID: 1707569
[No Abstract] [Full Text] [Related]
11. [Natural cytotoxic cells (NK) and their role in the immunological control of neoplasms].
Rupniewska ZM; Adamczyk MB
Postepy Hig Med Dosw; 1981; 35(1):37-52. PubMed ID: 6174960
[No Abstract] [Full Text] [Related]
12. An introduction to tumour immunology.
James K
Arch Immunol Ther Exp (Warsz); 1983; 31(6):795-808. PubMed ID: 6611141
[TBL] [Abstract][Full Text] [Related]
13. Prostaglandins and cyclic nucleotides as effectors in non-lymphocyte mediated surveillance processes ( short review).
Mastacchi R; Bartolini G; Orlandi M; Chiricolo M; Guerrini F; Franceschi C; Tomasi V
Anticancer Res; 1985; 5(2):167-70. PubMed ID: 3994309
[TBL] [Abstract][Full Text] [Related]
14. [Natural killers and macrophages: their activity in leukemias].
Fi FT
Eksp Med Morfol; 1985; 24(2):63-70. PubMed ID: 3933945
[No Abstract] [Full Text] [Related]
15. Tumor immunology--three decades in review.
Brodt P
Annu Rev Microbiol; 1983; 37():447-76. PubMed ID: 6227278
[No Abstract] [Full Text] [Related]
16. Basic and tumor immunology: a review.
Melvold RW; Sticca RP
Surg Oncol Clin N Am; 2007 Oct; 16(4):711-35, vii. PubMed ID: 18022541
[TBL] [Abstract][Full Text] [Related]
17. Immunological surveillance revisited.
Rygaard J; Povlsen CO
Tokai J Exp Clin Med; 1983 Dec; 8(5-6):529-32. PubMed ID: 6681345
[No Abstract] [Full Text] [Related]
18. The 'kiss of death' by dendritic cells to cancer cells.
Chan CW; Housseau F
Cell Death Differ; 2008 Jan; 15(1):58-69. PubMed ID: 17948029
[TBL] [Abstract][Full Text] [Related]
19. Immunosurveillance and immunotherapy of tumors by innate immune cells.
Iannello A; Thompson TW; Ardolino M; Marcus A; Raulet DH
Curr Opin Immunol; 2016 Feb; 38():52-8. PubMed ID: 26686774
[TBL] [Abstract][Full Text] [Related]
20. [NK cells--their role and importance in antitumor resistance].
Mircheva Zh
Eksp Med Morfol; 1984; 23(2):99-104. PubMed ID: 6205848
[No Abstract] [Full Text] [Related]
[Next] [New Search]
